<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04019483</url>
  </required_header>
  <id_info>
    <org_study_id>NL62233.041.17</org_study_id>
    <nct_id>NCT04019483</nct_id>
  </id_info>
  <brief_title>Improved Prediction of Recurrent Stroke and Detection of Small Volume Stroke</brief_title>
  <acronym>ENCLOSE</acronym>
  <official_title>Improved Prediction of Recurrent Stroke and Detection of Small Volume Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UMC Utrecht</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dutch Heart Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Netherlands Organisation for Scientific Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>UMC Utrecht</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rationale: Over 20.000 people suffer an ischemic stroke in the Netherlands each year. Large
      artery occlusions are easy to identify and can be treated with endovascular clot removal. 70%
      of patient will however suffer from a more distal occlusion resulting in small volume stroke
      or a transient ischemic attack (TIA). Small ischemic lesions are hard to detect with current
      acute stroke protocols. TIA and small volume stroke patients, are at an increased risk for
      recurrent stroke, making immediate diagnosis critical. Because thrombo-embolic sources often
      cause these strokes, identifying and treating the underlying aetiology has the potential to
      radically lower the risk of recurrence and improve the outcome of these patients.

      Objectives: 1) To identify clinical and imaging predictors of recurrent stroke; 2) To improve
      early detection of small volume stroke with admission computed tomography perfusion (CTP) in
      patients with suspected acute ischemic stroke with small volume stroke or no ischemia on
      admission imaging.

      Study design: Prospective, multicenter cohort study.

      Study population: All patients who visited the University Medical Center (UMC) Utrecht, the
      Amsterdam University Medical Centers (Amsterdam UMC), location Academic Medical Center (AMC)
      or the St. Antonius Hospital and who underwent a CT-scan of the brain within 9 hours after
      onset of stroke symptoms with an age ≥18 years. Within 36 months, 720 patients will be
      enrolled in the study. Of these patients, 300 patients will be included for the follow-up
      magnetic resonance imaging (MRI).

      Main study parameters/endpoints: The main study endpoints are: 1) Stroke recurrence rate at 2
      years; 2) Presence and volume of acute ischemic lesions on follow-up diffusion weighted
      imaging MRI.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 23, 2018</start_date>
  <completion_date type="Anticipated">March 2023</completion_date>
  <primary_completion_date type="Anticipated">March 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrent ischemic stroke</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Recurrent ischemic stroke</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>modified Rankin scale</measure>
    <time_frame>90 days</time_frame>
    <description>The modified Rankin Scale (mRS) is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. The scale runs from 0-6 with &quot;0&quot; being perfect health without symptoms to &quot;6&quot; being death.
0 - No symptoms.
- No significant disability. Able to carry out all usual activities, despite some symptoms.
- Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities.
- Moderate disability. Requires some help, but able to walk unassisted.
- Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted.
- Severe disability. Requires constant nursing care and attention, bedridden, incontinent.
- Dead.
9 - No data.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">720</enrollment>
  <condition>Ischemic Stroke</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients 18 years or older with acute stroke symptoms who visited the UMC Utrecht, the
        Amsterdam UMC, location AMC or the St. Antonius Hospital and who underwent a CT-scan within
        9 hours after onset of stroke symptoms.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥18 years;

          -  Time from symptom onset until imaging is &lt;9 hours*;

          -  Clinical diagnosis of acute ischemic stroke or TIA;

          -  Informed consent from patient or family after the admission scan (unless the patient
             died).

               -  Patients who awaken with stroke symptoms can only be included if they went to
                  sleep without any stroke symptoms and the time from going to sleep until imaging
                  is less than 9 hours.

        Exclusion Criteria:

          -  Patients with another diagnosis such as intracerebral hemorrhage, subarachnoid
             hemorrhage or tumor;

          -  Patients with known contrast allergy or renal failure.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Frans Kauw, MD</last_name>
    <phone>+3188-7571680</phone>
    <email>f.kauw-3@umcutrecht.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Amsterdam UMC, location AMC</name>
      <address>
        <city>Amsterdam</city>
        <state>Noord-Holland</state>
        <zip>1105 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Valeria Guglielmi, MD</last_name>
      <phone>+3120-5664591</phone>
      <email>v.guglielmi@amsterdamumc.nl</email>
    </contact>
    <investigator>
      <last_name>Charles B.L.M. Majoie, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Valeria Guglielmi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jonathan M. Coutinho, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Antonius Hospital</name>
      <address>
        <city>Nieuwegein</city>
        <state>Utrecht</state>
        <zip>3435 CM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wouter van Es, MD PhD</last_name>
      <phone>+3188-3208064</phone>
      <email>h.es@antoniusziekenhuis.nl</email>
    </contact>
    <investigator>
      <last_name>Wouter van Es, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Medical Center Utrecht</name>
      <address>
        <city>Utrecht</city>
        <zip>3584 CX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frans Kauw, MD</last_name>
      <phone>+31 88 75 716 80</phone>
      <email>f.kauw-3@umcutrecht.nl</email>
    </contact>
    <investigator>
      <last_name>Jan W Dankbaar, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frans Kauw, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Richard A.P. Takx, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 10, 2019</study_first_submitted>
  <study_first_submitted_qc>July 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 15, 2019</study_first_posted>
  <last_update_submitted>July 17, 2019</last_update_submitted>
  <last_update_submitted_qc>July 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>UMC Utrecht</investigator_affiliation>
    <investigator_full_name>Jan. W. Dankbaar, MD, PhD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Recurrence</keyword>
  <keyword>Infarct detection</keyword>
  <keyword>CT</keyword>
  <keyword>MRI</keyword>
  <keyword>Diagnosis</keyword>
  <keyword>Prognosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

